| Literature DB >> 32835921 |
Roberto B M Marano1, Telma Fernandes2, Célia M Manaia2, Olga Nunes3, Donald Morrison4, Thomas U Berendonk5, Norbert Kreuzinger6, Tanel Tenson7, Gianluca Corno8, Despo Fatta-Kassinos9, Christophe Merlin10, Edward Topp11, Edouard Jurkevitch12, Leonie Henn4, Andrew Scott13, Stefanie Heß14, Katarzyna Slipko6, Mailis Laht15, Veljo Kisand7, Andrea Di Cesare8, Popi Karaolia9, Stella G Michael9, Alice L Petre16, Roberto Rosal16, Amy Pruden17, Virginia Riquelme17, Ana Agüera18, Belen Esteban18, Aneta Luczkiewicz19, Agnieszka Kalinowska19, Anne Leonard20, William H Gaze20, Anthony A Adegoke21, Thor A Stenstrom22, Alfieri Pollice23, Carlo Salerno23, Carsten U Schwermer24, Pawel Krzeminski24, Hélène Guilloteau10, Erica Donner25, Barbara Drigo25, Giovanni Libralato26, Marco Guida26, Helmut Bürgmann27, Karin Beck27, Hemda Garelick28, Marta Tacão29, Isabel Henriques30, Isabel Martínez-Alcalá31, Jose M Guillén-Navarro31, Magdalena Popowska32, Marta Piotrowska32, Marcos Quintela-Baluja33, Joshua T Bunce33, Maria I Polo-López34, Samira Nahim-Granados34, Marie-Noëlle Pons35, Milena Milakovic36, Nikolina Udikovic-Kolic36, Jérôme Ory37, Traore Ousmane37, Pilar Caballero38, Antoni Oliver38, Sara Rodriguez-Mozaz39, Jose L Balcazar39, Thomas Jäger40, Thomas Schwartz40, Ying Yang41, Shichun Zou41, Yunho Lee42, Younggun Yoon42, Bastian Herzog43, Heidrun Mayrhofer43, Om Prakash44, Yogesh Nimonkar44, Ester Heath45, Anna Baraniak46, Joana Abreu-Silva2, Manika Choudhury28, Leonardo P Munoz28, Stela Krizanovic36, Gianluca Brunetti25, Ayella Maile-Moskowitz17, Connor Brown17, Eddie Cytryn47.
Abstract
The World Health Organization Global Action Plan recommends integrated surveillance programs as crucial strategies for monitoring antibiotic resistance. Although several national surveillance programs are in place for clinical and veterinary settings, no such schemes exist for monitoring antibiotic-resistant bacteria in the environment. In this transnational study, we developed, validated, and tested a low-cost surveillance and easy to implement approach to evaluate antibiotic resistance in wastewater treatment plants (WWTPs) by targeting cefotaxime-resistant (CTX-R) coliforms as indicators. The rationale for this approach was: i) coliform quantification methods are internationally accepted as indicators of fecal contamination in recreational waters and are therefore routinely applied in analytical labs; ii) CTX-R coliforms are clinically relevant, associated with extended-spectrum β-lactamases (ESBLs), and are rare in pristine environments. We analyzed 57 WWTPs in 22 countries across Europe, Asia, Africa, Australia, and North America. CTX-R coliforms were ubiquitous in raw sewage and their relative abundance varied significantly (<0.1% to 38.3%), being positively correlated (p < 0.001) with regional atmospheric temperatures. Although most WWTPs removed large proportions of CTX-R coliforms, loads over 103 colony-forming units per mL were occasionally observed in final effluents. We demonstrate that CTX-R coliform monitoring is a feasible and affordable approach to assess wastewater antibiotic resistance status.Entities:
Keywords: Antibiotic resistance; Coliforms; ESBLs; Wastewater treatment; Water reuse
Mesh:
Substances:
Year: 2020 PMID: 32835921 DOI: 10.1016/j.envint.2020.106035
Source DB: PubMed Journal: Environ Int ISSN: 0160-4120 Impact factor: 9.621